Literature DB >> 14680314

Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer.

Bernard H Bochner1, James E Montie, Cheryl T Lee.   

Abstract

A surveillance program following cystectomy should consider a patient's individual risk for the development of local and distant recurrences and any specific needs related to the urinary tract reconstruction performed (Table 1). Well-documented recurrence patterns following cystectomy are available from many large surgical series and provide the background information needed for tailoring follow-up based on pathologic criteria. Economic issues also must be considered, given that the health care-related expenses of treating and following patients with bladder cancer is twice as much as that expended for the treatment of prostate cancer. Because of the ever-increasing fiscal constraints placed on clinicians, risk-adjusted follow-up strategies are reasonable, but will require prospective evaluation to validate their appropriateness.

Entities:  

Mesh:

Year:  2003        PMID: 14680314     DOI: 10.1016/s0094-0143(03)00061-2

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  10 in total

Review 1.  [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy].

Authors:  A Heidenreich; D Porres; D Pfister
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

2.  A plea for a uniform surveillance schedule after radical cystectomy.

Authors:  Guido Dalbagni; Bernard H Bochner; Angel Cronin; Harry W Herr; S Machele Donat
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

3.  [Peritoneal carcinomatosis after robotic-assisted radical cystectomy].

Authors:  R Epplen; D Pfister; A Heidenreich
Journal:  Urologe A       Date:  2011-11       Impact factor: 0.639

Review 4.  [Follow-up of bladder cancer : The right examinations at the right time].

Authors:  P Olbert; P J Goebell; A Hegele
Journal:  Urologe A       Date:  2018-06       Impact factor: 0.639

5.  Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Dong Hyeon Lee; Wan Song
Journal:  Cancer Manag Res       Date:  2020-08-03       Impact factor: 3.989

6.  Surveillance strategies after definitive therapy of invasive bladder cancer.

Authors:  Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.

Authors:  Jing Xie; Xue-Bin Zhang; Jin Wen; Yu-Shi Zhang; Han-Zhong Li
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

8.  Monitoring of the upper urinary tract in patients with bladder cancer.

Authors:  Rajinikanth Ayyathurai; Mark S Soloway
Journal:  Indian J Urol       Date:  2011-04

Review 9.  Imaging and Management of Bladder Cancer.

Authors:  Vincenzo K Wong; Dhakshinamoorthy Ganeshan; Corey T Jensen; Catherine E Devine
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

10.  Muscle invasive bladder cancer: from diagnosis to survivorship.

Authors:  N E Mohamed; M A Diefenbach; H H Goltz; C T Lee; D Latini; M Kowalkowski; C Philips; W Hassan; S J Hall
Journal:  Adv Urol       Date:  2012-08-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.